Literature DB >> 10808180

DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization.

S J Kornfeld1, B Zeffren, C S Christodoulou, N K Day, G Cawkwell, R A Good.   

Abstract

BACKGROUND: DiGeorge anomaly (DGA) is defined as a field defect characterized by dysmorphic facies, hypoparathyroidism, congenital heart defects, and a deficiency in cell-mediated immunity, usually associated with a microdeletion in chromosome 22q11.2. Data correlating clinical and genetic information, especially in terms of the extent of the immunodeficiency and infectious complications, are scant.
OBJECTIVE: The goal of this study was to define the severity of the immunodeficiency and infectious illnesses in DGA patients with characteristic clinical and genetic findings and compare them with a similar group of patients without a microdeletion in chromosome 22q11.2.
METHODS: A retrospective chart review of patients referred for evaluation of DGA to our immunology service from 1989 to 1995 was conducted. Clinical and immunologic data were collected from their initial evaluation. Patients meeting at least 3 of 4 of these criteria were considered to meet strict clinical diagnostic criteria for DGA, and the results of analysis for a microdeletion in chromosome 22q11.2 for each patient was noted.
RESULTS: Sixteen of the 22 patients meeting strict clinical criteria for DGA were available for analysis for the microdeletion at chromosome 22q.11.2. Of these, 13 (81%) were positive by fluorescence in situ hybridization (FISH); 9 of 13 (69%) had low CD3 numbers, 6 of 10 assayed (60%) had low thymulin levels; 10 of 13 (77%) had low CD4 numbers, and 10 of 12 (83%) had absent or small thymus glands. B cells were increased in 9 of 13 (69%) patients. Mitogen and antigen responses were normal in 6 of 7 (86%) patients tested. Eight of 13 (62%) had a history of increased frequency of infectious illnesses. All had recurrent respiratory infections, including sinusitis, otitis media, and pneumonia. Three of the 16 patients tested (19%) were FISH negative. Two of 3 (67%) had low CD3 and CD4 numbers. B cells were elevated in all patients. All had recurrent respiratory infections, low thymulin levels, and absent thymus glands.
CONCLUSIONS: Contrary to traditional descriptions, this group of clinically and genetically defined patients with DGA had a predominantly mild cell-mediated immunodeficiency syndrome usually associated with infections characteristic of humoral immunodeficiencies. The patients who were FISH positive did not differ significantly from those that were FISH negative in terms of clinical and immunologic findings or infectious complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10808180     DOI: 10.1067/mai.2000.105527

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.

Authors:  Kiran A Gul; Torstein Øverland; Liv Osnes; Lars O Baumbusch; Rolf D Pettersen; Kari Lima; Tore G Abrahamsen
Journal:  J Clin Immunol       Date:  2015-03-27       Impact factor: 8.317

2.  Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice.

Authors:  Rodolfo G Goya; Paula C Reggiani; Silvan M Vesenbeckh; Jean M Pléau; Yolanda E Sosa; Gloria M Cónsole; Rüdiger Schade; Peter Henklein; Mireille Dardenne
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-03-27       Impact factor: 4.310

3.  Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.

Authors:  A R Gennery; D Barge; J J O'Sullivan; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

Review 4.  DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.

Authors:  K E Sullivan
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

5.  Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.

Authors:  P Eberle; C Berger; S Junge; S Dougoud; E Valsangiacomo Büchel; M Riegel; A Schinzel; R Seger; T Güngör
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

6.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

7.  Goldenhar syndrome: a cause of secondary immunodeficiency?

Authors:  Serge De Golovine; Shuya Wu; Jill V Hunter; William T Shearer
Journal:  Allergy Asthma Clin Immunol       Date:  2012-07-02       Impact factor: 3.406

8.  Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome.

Authors:  Nico J M van Beveren; Lianne C Krab; Sigrid Swagemakers; Gabriella Buitendijk; Gabriëlle H S Buitendijk; Erik Boot; Peter van der Spek; Ype Elgersma; Therese A M J van Amelsvoort
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

9.  Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.

Authors:  Mingyan Lin; Erika Pedrosa; Anastasia Hrabovsky; Jian Chen; Benjamin R Puliafito; Stephanie R Gilbert; Deyou Zheng; Herbert M Lachman
Journal:  BMC Syst Biol       Date:  2016-11-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.